PLXS
PlexusCAI scenario view
RankAlpha Sentiment CodexAI sentiment snapshot
AI commentary
As of April 29, 2026, the live quote check showed PLXS around $251.25 versus the April 28, 2026 anchor close of $246.33, an initial post-earnings gain of roughly 2.0%. The immediate tone is positive because the company beat its own Q2 guide and raised the next-quarter revenue base, but the reduction in full-year free-cash-flow expectations offsets some of that enthusiasm. No trustworthy post-print analyst target or rating revisions were confirmed in this T+1 pass, and coverage appears thin, so the setup still reads as a cautious monitoring view rather than a high-conviction chase despite the favorable first reaction.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
Plexus reported fiscal Q2 revenue of $1.164 billion versus prior guidance of $1.110 billion to $1.150 billion, non-GAAP EPS of $2.05 versus prior guidance of $1.80 to $1.95, and initiated fiscal Q3 revenue guidance of $1.200 billion to $1.250 billion with non-GAAP EPS of $2.02 to $2.18. The key near-term test is whether the April 30, 2026 earnings call and early buy-side digestion sustain this stronger growth and margin setup. [#8-K-2026-04-29]
Despite better Q2 cash-cycle execution and $16.0 million of free cash flow in the quarter, management reduced fiscal 2026 free-cash-flow expectations to $50 million to $75 million from the approximately $100 million outlook it reaffirmed after Q1. The same 8-K also disclosed CFO Patrick J. Jermain's planned retirement, with David Abuhl assuming the CFO role on May 11, 2026; together, that keeps working-capital execution and leadership transition in focus into the next print. [#8-K-2026-04-29]
Management said fiscal Q2 included 30 manufacturing program wins representing a record $355 million of annualized revenue when fully ramped, with wins spanning aerospace and defense, surgical and imaging, data center power solutions, and semiconductor capital equipment. If conversion stays on schedule, Plexus has a credible path to sustain above-trend growth in its regulated and higher-complexity niches beyond this quarter. [#8-K-2026-04-29] [#10-K-2025-11-14]
Recommendation
No formal recommendation provided.

